DDX23 and cancer: DDX23 mutations and homozygous deletions have been identified in several different cancers, including adenoid cystic carcinoma (ACC), implicating DDX23 loss as a potential source of genomic instability which may have an important role in cancer development (Sridhara et al., 2017).